109 reports of this reaction
4.0% of all ARGATROBAN reports
#3 most reported adverse reaction
INTERNATIONAL NORMALISED RATIO INCREASED is the #3 most commonly reported adverse reaction for ARGATROBAN, manufactured by Accord Healthcare Inc.. There are 109 FDA adverse event reports linking ARGATROBAN to INTERNATIONAL NORMALISED RATIO INCREASED. This represents approximately 4.0% of all 2,692 adverse event reports for this drug.
Patients taking ARGATROBAN who experience international normalised ratio increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTERNATIONAL NORMALISED RATIO INCREASED is moderately reported among ARGATROBAN users, representing a notable but not dominant share of adverse events.
In addition to international normalised ratio increased, the following adverse reactions have been reported for ARGATROBAN:
The following drugs have also been linked to international normalised ratio increased in FDA adverse event reports:
INTERNATIONAL NORMALISED RATIO INCREASED has been reported as an adverse event in 109 FDA reports for ARGATROBAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTERNATIONAL NORMALISED RATIO INCREASED accounts for approximately 4.0% of all adverse event reports for ARGATROBAN, making it one of the most commonly reported side effect.
If you experience international normalised ratio increased while taking ARGATROBAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.